About: Silexion Therapeutics Corp, a clinical-stage biotechnology company, discovers and develops RNA interference (RNAi) therapies for KRAS-driven cancers. Its products comprise SIL204 second-generation small interfering RNA (siRNA) undergoing phase 2/3 clinical evaluation for pancreatic cancer and silence mutant KRAS oncogene expression. The company was founded in 2008 and is headquartered in Ramat Gan, Israel.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.15 (+0.13%)
SLXN NASDAQ Silexion Therapeutics Corp
Silexion Therapeutics Corp share price
Atividade de preço de SLXN
Último preço
$ 0,150
Variação (24h)
0,00 USD (0,13%)
Volume
125.22K
Volume (média 4 sem.)
-
Abertura
$ 0,15
Variação do dia
$ 0,15 - $ 0,16
Fechamento anterior
$ 0,15
Último negócio
04 Nov, 9:00 pm GMT+0
Atrasado
04 Nov, 9:00 pm GMT+0
SLXN price performance
Atrasado
04 Nov, 9:00 pm GMT+0
SLXN details
quote.marketSignals